(MedPage Today) — Polyclonal antithymocyte globulin (ATG), an old agent used to suppress the immune system and destroy T cells, reduced the loss of β-cell function in young people newly diagnosed with type 1 diabetes, the randomize phase…
Source link : https://www.medpagetoday.com/meetingcoverage/easd/117568
Author :
Publish date : 2025-09-19 22:31:00
Copyright for syndicated content belongs to the linked Source.
